The pharmacological profiles of the 5-hydroxytryptamine (5-HT) receptors on
Ascaris suum pharyngeal and somatic body wall muscles were investigated. T
he mechanisms involved following activation of these receptors were also st
udied. 5-HT activated and maintained pumping in isolated pharynxes with an
EC-50 value of 44 +/- 1.7 muM. The 5-HT agonists, tryptamine, sumatriptan 8
-OH-DPAT and 5-carboxyamidotryptamine all failed to stimulate pumping. The
5-HT2 antagonist, ketanserin, initially excited and then inhibited pumping
while the 5-HT4 antagonist, ondansetrun, had no effect. 5-HT and 5-HT agoni
sts, 8-OH-DPAT, 5-carboxyamidotryptamine, alpha -methyl-5-HT and tryptamine
all inhibited ACh-induced contractions of a somatic body wall muscle strip
. Ketanserin partially blocked the inhibitory effect of alpha -methyl-5-HT
and ACh-induced contractions while the 5-HT uptake blocker, fluoxetine, pot
entiated the effect of 5-HT on ACh-induced contractions. Basal levels of cA
MP, 1540 +/- 232 pmol/mg, in pharyngeal muscle and 1721 +/- 134 pmol/ mg, s
omatic body wall muscle, were both increased by forskolin. 5-HT had no effe
ct on pharyngeal muscle cAMP levels but raised cAMP levels in somatic body
wall muscle, e.g. 100 muM 5-HT, raised the level to 2851 +/- 212 pmol/mg an
d 1000 muM raised levels to 4578 +/- 1234 pmol/mg. 5-HT, 1000 muM, increase
d inositol phosphate levels in pharyngeal muscle. These results provide som
e evidence for a 5-HT2-like receptor on pharyngeal muscle. In contrast, the
situation on somatic body wall muscle is more confusing since the pharmaco
logical profile partly indicates a 5-HT2-like receptor but this receptor is
linked to a rise in cAMP levels. Further studies are required to resolve t
he position but they. must be based on the rational design of ligands speci
fically for nematode 5-HT receptors and not simply using ligands developed
for the classification of mammalian 5-HT receptors. Such a design must take
into account data from molecular biology studies of nematode 5-HT receptor
s.